Cargando…

microRNA, the Innate-Immune System and SARS-CoV-2

The single-stranded viral RNA (ssvRNA) known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 can be effectively inactivated by a number of natural ribonucleic acid-based host cell defenses. One of the most important of these defenses includes the actions of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, James M., Lukiw, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245018/ https://www.ncbi.nlm.nih.gov/pubmed/35782132 http://dx.doi.org/10.3389/fcimb.2022.887800

Ejemplares similares

microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection—A Commentary
por: Lukiw, Walter J.
Publicado: (2021)

SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3
por: Freitas, Raul S., et al.
Publicado: (2022)

SARS-CoV-2 infection of intestinal epithelia cells sensed by RIG-I and DHX-15 evokes innate immune response and immune cross-talk
por: Zhang, Lijuan, et al.
Publicado: (2023)

Interactions Between Specific Immune Status of Pregnant Women and SARS-CoV-2 Infection
por: Chen, Ruirong, et al.
Publicado: (2021)

Longitudinal anti-SARS-CoV-2 antibody immune response in acute and convalescent patients
por: Pérez-Juárez, Horacio, et al.
Publicado: (2023)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms
por: Li, Jiaqi, et al.
Publicado: (2022)

Vitality of Proteinase K in rRTPCR Detection of SARS-CoV2 Bypassing RNA Extraction
por: Shukla, Alka, et al.
Publicado: (2021)

SARS-CoV-2: The Monster Causes COVID-19
por: Song, Chang, et al.
Publicado: (2022)

SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
por: Ning, Shuo, et al.
Publicado: (2021)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Liu, Yijun, et al.
Publicado: (2021)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023)

SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
por: Chaubey, Ishaan, et al.
Publicado: (2021)

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
por: Liu, Fengming, et al.
Publicado: (2021)

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador
por: Guevara, Rommel, et al.
Publicado: (2022)

SARS-CoV-2 induced hepatic injuries and liver complications
por: Saeed, Umar, et al.
Publicado: (2022)

Choosing a cellular model to study SARS-CoV-2
por: Pires De Souza, Gabriel Augusto, et al.
Publicado: (2022)

Gastrointestinal (GI) Tract Microbiome-Derived Neurotoxins—Potent Neuro-Inflammatory Signals From the GI Tract via the Systemic Circulation Into the Brain
por: Lukiw, Walter J.
Publicado: (2020)

Endogenous miRNA-Based Innate-Immunity against SARS-CoV-2 Invasion of the Brain
por: Lukiw, Walter J., et al.
Publicado: (2023)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms
por: Thom, Ruth E., et al.
Publicado: (2021)

Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing
por: Zhang, Jie, et al.
Publicado: (2020)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
por: Wang, Mei-Yue, et al.
Publicado: (2020)

Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces
por: Wu, Wenrui, et al.
Publicado: (2022)

SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
por: Mishra, Tarun, et al.
Publicado: (2021)

Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells
por: Shaharuddin, Syairah Hanan, et al.
Publicado: (2021)

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2
por: Zeng, Weijie, et al.
Publicado: (2022)

The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
por: Wang, Yifei, et al.
Publicado: (2022)

Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection
por: Deroubaix, Aurélie, et al.
Publicado: (2022)

The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors
por: Diarimalala, Rominah Onintsoa, et al.
Publicado: (2023)

Host mitochondria: more than an organelle in SARS-CoV-2 infection
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota
por: Tieu, Vivian, et al.
Publicado: (2023)

A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection
por: Azmi, Iqbal, et al.
Publicado: (2021)

MicroRNA and Nonsense Transcripts as Putative Viral Evasion Mechanisms
por: Bakre, Abhijeet A., et al.
Publicado: (2019)

Innate immunity in rickettsial infections
por: Londoño, Andrés F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o09gfmbuip92ol8suve0nhvjfr